Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and β-cell dysfunction

Diabetes

Volumn 45, Issue 8, 1996, Pages 1094-1101

  Couce, Marta ^a   Kane, Laurie A ^a   O'Brien, Timothy D ^c   Charlesworth, Jon ^a   Soeller, Walter ^b   McNeish, John ^b   Kreutter, David ^b   Roche, Patrick ^a   Butler, Peter C ^a,d  

^a MAYO CLINIC   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; DEXAMETHASONE; GLUCOSE; INSULIN; RECOMBINANT GROWTH HORMONE;

AMYLOIDOSIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; STEROID THERAPY;

EID: 0029742232     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.45.8.1094     Document Type: Article

References (33)

1. Maloy AL, Longnecker DS, Greenberg ER: The relation of islet amyloid to the clinical type of diabetes. Hum Pathol 12:917-922,1981
2. Howard CF: Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia 29:301-306,1986
3. Clark A, Cooper GJS, Lewis CE, Morris JF, Willis AC, Reid KBM, Turner RC: Islet amyloid formed from diabetes associated peptide may be pathogenic in type 2 diabetes. Lancet ii:231-234,1987
4. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH: Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci 84:3881-3885,1987
5. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM: Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci 84:8628-8632,1987
6. Lukinius A, Wilander E, Westermark GT, Engstrom U, Westermark P: Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 32:240-244,1989
7. Butler PC, Chou J, Carter WB, Wang Y-N, Bu B-H, Chang D, Chang J-K, Rizza RA: Effects of meal ingestion on plasma amylin concentrations in NIDDM and nondiabetic humans. Diabetes 39:752-756,1990
8. Hartter E, Svoboda T, Ludvik B, Schuller M, Lell B, Kuenburg E: Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia 34:52-54,1991
9. Mitsukawa T, Takemura J, Asai J, Nakazato M, Kangawa K, Matsuo H, Matsukura S: Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration. Diabetes 39:639-642,1990
10. Betsholz C, Svensson V, Rorsman F, Engstrom U, Westermark GT, Wilander E, Johnson K, Westermark P: Islet amyloid polypeptide (IAPP): cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus. Exp Cell Res 183:484-493,1989
11. Westermark P, Engström U, Johnson KH, Westermark GT, Betsholtz C: Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 87:5036-5040,1990
12. de Konig EJ, Hoppener JW, Verbeek JS, Oosterwijk C, van Hulst KL, Baker CA, Lips CJ, Morris JF, Clark A: Human islet amyloid polypeptide accumulates at similar sites in islets of transgenic mice and humans. Diabetes 43:640-644,1994
13. Johnson KH, O'Brien TD, Hayden DW, Jordan K, Ghobrial HKG, Mahoney WC, Westermark P: Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques. Am J Pathol 130:1-8,1988
14. O'Brien TD, Butler AE, Johnson KH, Roche PC, Butler PC: Islet amyloid polypeptide (IAPP) in human insulinomas: evidence for intracellular amyloidogenesis. Diabetes 43:329-336,1994
15. Butler PC, Eberhardt NL, O'Brien TD: Islet amyloid polypeptide (IAPP) and insulin secretion. In Molecular Biology of Diabetes. Draznin B, LeRoith D, Eds. Totowa, New Jersey, Humana Press, 1994, p. 381-398
16. O'Brien TD, Butler PC, Kreutter DK, Kane LA, Eberhardt NL: Human islet amyloid polypeptide expression in COS-1 cells: an in vitro model of intracellular amyloidogenesis. Am J Pathol 147:609-616,1995
17. Hoppener JWM, Verbeek JS, de Koning EJP, Oosterwijk C, van Hulst KL, Visser-Vernooy JH, Hofhuis FMA, van Gaalen S, Berends MJH, Hackeng WHL, Jansz HS, Morris JF, Clark A, Capel PJA, Lips CJM: Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycemia or hyperinsulinemia. Diabetologia 36:1258-1265,1993
18. D'Alessio DA, Verchere CB, Kahn SE, Hoagland V, Baskin DG, Palmiter RD, Ensinck JW: Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes 43:1457-1461,1994
19. Yagui K, Yamaguchi TG, Kanatsuka A, Shimada F, Huang CI, Tokuyama Y, Ohsawa H, Yamamura K, Miyazaki J, Mikata A, Yoshida S, Makino H: Formation of islet amyloid fibrils in beta-secretory granules of TG mice expressing human islet amyloid polypeptide/amylin. Eur J Endocrinol 132:487-496,1995
20. Horber FF, Marsh HM, Haymond MW: Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes 40:141-149,1991
21. Marshall BA, Ren J-M, Johnson DW, Gibbs EM, Lillquist JS, Soeller WC, Holloszy JO, Mueckler M: Germline manipulation of glucose Homeostasis via alteration of glucose transporter levels in skeletal muscle. J Biol Chem 268:18442-18445,1993
22. Mosselman S, Hoppener JWM, Lips CJM, Jansz HS: The complete islet amyloid polypeptide precursor is encoded by two exons. FEBS Lett 247:154-158,1989
23. Sanger F, Nicklen S, Coulson AR: DNA Sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467,1977
24. Mosselman S, Hoppener JWM, de Wit L, Soeller W, Lips CJM, Jansz HS: IAPP/amylin gene transcriptional control region: evidence for negative regulation. FEBS Lett 271:33-36,1990
25. Innis MA, Gelfand DH, Sninsky JJ, White TJ (Eds.): PCR Protocols. New York, Academic Press,1990
26. Westermark G, Arora MB, Fox N, Carroll R, Chan SJ, Westermark P, Steiner DF: Amyloid formation in response to B cell stress occurs in vitro, but not in vivo, in islets of transgenic mice expressing human islet amyloid polypeptide. Molecular Med 1:542-553,1995
27. Lukens FDW, Dohan FC: Pituitary-diabetes in the cat: recovery following insulin or dietary treatment. Endocrinology 30:175-201,1942
28. Lukens FDW, Dohan FC, Wolcott MW: Pituitary-diabetes in the cat: recovery following phlorhizin treatment. Endocrinology 32:475-486,1943
29. Lorenzo A, Razzaboni B, Weir GC, Yankner BA: Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368:756-760,1994
30. Jarratt JT, Lansbury PT: Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73:1055-1058,1993
31. Ohsawa H, Kanatsuka A, Yamaguchi T, Makino H, Yoshida S: Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. Biochem Biophys Res Commun 160:961-967,1989
32. Silvestre RA, Pieró E, Dégano P, Miralles P, Marco J: Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas. Regul Pept 31:23-31,1990
33. Leighton B, Cooper GJS: Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335:632-635,1988